Sat.Dec 19, 2020 - Fri.Dec 25, 2020

article thumbnail

MHRA approves Polyphor’s phase 1 trial of novel inhaled antibiotic

Pharma Times

Murepavadin is being developed to treat Pseudomonas aeruginosa infections in people with cystic fibrosis

150
150
article thumbnail

Boston Doctor Develops Severe Allergic Reaction After Getting Moderna Vaccine

NY Times

The patient, who has a severe shellfish allergy, recovered quickly with treatment. Until now, reports of severe reactions had been linked to the Pfizer vaccine.

Vaccines 145
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

DNA analysis could pinpoint ‘long haulers’ among COVID-19 patients

Outsourcing Pharma

The analytical tool, developed via Bionano Genomics, maps structural variations in DNA that are known to cause disease and are tied to symptom severity.

144
144
article thumbnail

UK prepares for decision on AZ/Oxford vaccine as COVID cases soar

pharmaphorum

The UK’s COVID-19 vaccination programme could get a speed boost, with the country’s drugs regulator expected to make a decision on a shot from Oxford University/AstraZeneca in the next few days. If the vaccine becomes available the UK will be able to step up its vaccination programme as large swathes of the country face draconian “Tier 4” restrictions due to the emergence of as more infectious variant.

Vaccines 126
article thumbnail

Navigating Payroll Compliance: Future-Proofing Payroll in an Evolving Regulatory Landscape

Speaker: Jennifer Hill

Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.

article thumbnail

Green light for AZ’s Tagrisso in early-stage lung cancer

Pharma Times

EGFR-TKI approved in the US for early non-small cell lung cancer

146
146

More Trending

article thumbnail

‘Explosion’ of health data fuels pharma advances: Linguamatics

Outsourcing Pharma

A leader from the IQVIA company explains how the boom in the volume and quality of data, and advanced analysis, can speed and streamline drug development.

article thumbnail

The top 5 pharma M&A deals of 2020

pharmaphorum

2020’s M&A activity hasn’t quite reached the heights of last year’s, where two pharma mega-mergers – BMS’ buyout of Celegne and AbbVie’s acquisition of Allergan – accounted for almost 40% of total M&A deal values. That said, there were still some interesting moves indicating new directions of travel for big pharma players – with most deals focused on specific drugs from biotechs, particularly in cancer (though we did get rumours of an AstraZeneca-Gilead merger , which would have been the

article thumbnail

Vicore Pharma’s C21 med shows promise in COVID-19 study

Pharma Times

Drug is being studied in hospitalised COVID-19 patients

141
141
article thumbnail

Turkey and Brazil Say Chinese Vaccine Effective, With Sparse Supporting Data

NY Times

The clinical trial in Turkey was much smaller than those of other major vaccine candidates, making the researchers’ claims for it less certain.

article thumbnail

From Diagnosis to Delivery: How AI is Revolutionizing the Patient Experience

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

article thumbnail

Ingredients, innovation and a need for speed: what’s in store for 2021

Outsourcing Pharma

Three leaders from pharma ingredients and innovation firm Lonza share views on challenges and opportunities likely to face the industry in coming months.

105
105
article thumbnail

5 ways digital health, and digital pharma, changed in 2020

pharmaphorum

Reviewing 2019’s key digital health stories last year I suggested that, while big strides continued to be made, any definitive ‘coming of age’ moment for the sector was unlikely. But that was before the first reports emerged of a highly contagious coronavirus and 2020 will be forever associated with COVID-19 and the global devastation and disruption it has wrought.

article thumbnail

Aimmune’s peanut allergy med Palforzia wins EU approval

Pharma Times

Drug becomes first treatment for peanut allergy in the EU

137
137
article thumbnail

Coronavirus Vaccine Distribution Could Get Chaotic

NY Times

There are already signs that the rollout will be messy, confusing and chaotic.

article thumbnail

Why Every Small Business Needs an HCM Solution: A Comprehensive Guide

Managing HR tasks like payroll, compliance, and employee data can overwhelm small businesses. That’s where a Human Capital Management (HCM) solution comes in. Our eBook, Why Every Small Business Needs an HCM Solution: A Comprehensive Guide , shows how an HCM system automates tedious processes, ensuring your business stays compliant and efficient. You’ll learn how to simplify payroll, eliminate costly errors, and empower your employees with self-service tools.

article thumbnail

Collaboration to chart AI-generated map of the immune system

Outsourcing Pharma

A partnership between Immunai and 10x Genomics will use artificial intelligence to create a map of the immune system to help accelerate drug development.

article thumbnail

Moderna and BioNTech – who are they?

pharmaphorum

Moderna and BioNTech, two rising stars in biotech, were in the limelight this year with their pioneering mRNA vaccines against COVID-19. Just who are these companies and who is behind them, asks Richard Staines. A year ago, the names Moderna and BioNTech were known mainly to those who followed biotech and pharma dealings. But the tragic events of 2020 have meant these companies have become household names as their trailblazing mRNA vaccines became the first to be approved by regulators against t

Vaccines 109
article thumbnail

AMO Pharma launches late-stage study of CMD candidate

Pharma Times

REACH-CDM study was based on results of positive phase II data

130
130
article thumbnail

Ex-Bloomberg Reporter Christie Smythe Who Covered Martin Shkreli Reveals Relationship With Him

NY Times

Christie Smythe helped break the story of Mr. Shkreli’s arrest in 2015. Then she “started to fall for him,” she said, and quit her job at Bloomberg News.

82
article thumbnail

Position Your Pharmacy for Expansion

Speaker: Chris Antypas and Josh Halladay

Access to limited distribution drugs and payer contracts are key to pharmacy expansion. But how do you prepare your operations to take the next step? Meaningful data: Collect and share clinical data regarding outcomes, utilization, and more Reporting: Limited distribution models require efficient tracking and reporting systems Workflows: Align workflows with specific pharma and payer contractual requirements For in-depth, expert insights on pharmacy expansion, watch this webinar from Inovalon.

article thumbnail

Supply chain woes can lead to billion-dollar problems: Cloudleaf

Outsourcing Pharma

A new survey from the supply-chain analysis company revals inefficiencies, inaccurate data and other flaws can be costly in terms of revenue, reputation and patient lives.

93
article thumbnail

Servier beefs up in cancer, buying Agios’ oncology business for $1.8bn

pharmaphorum

French pharmaceutical company Servier has swooped on Agios Pharma’s marketed and experimental cancer drugs, buying the entire franchise in a deal that leaves the US biopharma focused on genetic disorders. It’s a major change of direction for Boston-based Agios, which has been concentrating on the oncology market since its inception in 2008, bringing the Bristol Myers Squibb-partnered Tibsovo (ivosidenib) for IDH1-mutant acute myeloid leukaemia to the US market.

article thumbnail

Amgen files KRAS inhibitor sotorasib with EMA

Pharma Times

Submission supported by results from phase II CodeBreaK 100 study

130
130
article thumbnail

What to Know of Covid-19 Antibody Drugs: Cost, Availability and More

NY Times

Here’s information about who these therapies can help, how much they cost and how to find out if you can get them where you live.

80
article thumbnail

Best Practices to Streamline Compensation Management: A Foundation for Growth

Speaker: Joe Sharpe and James Carlson

Payroll optimization can be one of the most time-consuming and complex factors of small business management. Yet, organizations that crack the code on streamlining employee compensation often discover innovative avenues for growth. With the right strategies in place, outsourcing and streamlining payroll processes can result in substantial time and resource savings.

article thumbnail

Which pharmaceutical companies have the most drug patents in Sweden?

Drug Patent Watch

This chart shows the pharmaceutical companies with the most patents in Sweden. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…. The post Which pharmaceutical companies have the most drug patents in Sweden? appeared first on DrugPatentWatch - Make Better Decisions.

article thumbnail

AZ’s Tagrisso gets new early lung cancer use in US

pharmaphorum

AstraZeneca’s Tagrisso (osimertinib) has been approved by the FDA in a new lung cancer indication that extends its use to a group of patients with early-stage disease. The new use covers adjuvant treatment of adult patients with early-stage epidermal growth factor receptor-mutated (EGFRm) non-small cell lung cancer (NSCLC) after a potentially curative operation.

98
article thumbnail

Shionogi’s novel antibiotic added to UK’s pilot subscription reimbursement model

Pharma Times

Payment for drug linked to value to NHS rather than volume used

130
130
article thumbnail

Que no te engañen: las vacunas contra la COVID-19 no tienen microchips

NY Times

La vacuna de Pfizer tiene 10 ingredientes. Ninguno puede rastrear tu ubicación.

article thumbnail

Enhance Healthcare Efficiency With Top Payroll & HCM Services

Running a healthcare facility requires precision and care, not just for patients but also for your staff. Our guide, "A Buyer’s Guide to Payroll & HCM Services," helps healthcare providers choose the best provider. Efficient payroll management ensures timely, accurate payments, critical for maintaining staff morale and trust. Compliance support helps navigate complex healthcare regulations and avoid costly fines.